MGX — METAGENOMI THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 44 SEC-registered investment managers reported holding MGX (METAGENOMI THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $7.79M across 6.55M shares. That is -4.5% by share count (-289.30K shares) versus the previous quarter, while reported value moved -15.1%. Ownership is concentrated: the five largest holders account for 51.8% of reported value and the top ten for 76.5%.
Compared with the prior quarter, 5 opened new positions, 12 added to existing stakes, 13 trimmed, 9 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of METAGENOMI THERAPEUTICS INC (MGX) include Novo Holdings A/S, Principal Global Investors, RA CAPITAL MANAGEMENT, L.P., ranked by reported 13F value among the 141 institutional holders on this page.
MGX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 27 | 3.29M | $3.49M | -5.5% |
| Q2 2026 | 44 | 6.55M | $7.79M | -4.5% |
| Q1 2026 | 48 | 6.63M | $8.88M | -6.1% |
| Q4 2025 | 54 | 6.93M | $11.23M | +19.0% |
| Q3 2025 | 55 | 5.97M | $14.14M | -14.5% |
| Q2 2025 | 66 | 7.42M | $9.96M | -13.3% |
| Q1 2025 | 81 | 9.45M | $12.85M | -6.7% |
| Q4 2024 | 76 | 9.95M | $35.87M | +32.1% |
Over the 8 quarters shown, institutional share counts decreased 67% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (+32.1%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.08M | $1.14M | 0.00% | Hold | |
| 624.30K | $661.76K | 0.00% | Reduce | |
| 490.99K | $520.45K | 0.39% | Reduce | |
| 275.09K | $291.74K | 0.00% | Reduce | |
| 253.24K | $268.43K | 0.00% | Reduce | |
| 171.25K | $181.53K | 0.00% | Hold | |
| 119.85K | $127.04K | 0.00% | Hold | |
| 64.02K | $67.86K | 0.00% | Hold | |
| 52.29K | $55.00K | 0.00% | New | |
| 37.29K | $39.53K | 0.01% | Hold | |
| 37.20K | $39.43K | 0.00% | New | |
| 22.82K | $24.19K | 0.00% | Reduce | |
| 15.91K | $16.86K | 0.00% | Add | |
| 13.39K | $14.20K | 0.00% | Hold | |
| 12.80K | $13.56K | 0.00% | Hold | |
| 6.37K | $6.75K | 0.00% | Add | |
| 4.05K | $6.00K | 0.00% | New | |
| 5.50K | $5.83K | 0.00% | Hold | |
| 4.50K | $4.77K | 0.00% | Hold | |
| 1.89K | $2.11K | 0.00% | Hold | |
| 1.60K | $1.80K | 0.00% | Hold | |
| 1.10K | $1.17K | 0.00% | Add | |
| 500 | $595 | 0.00% | Hold | |
| 500 | $575 | 0.00% | Hold | |
| 21 | $22 | 0.00% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.08M | $1.28M | 0.00% | Add | |
| 742.40K | $883.46K | 0.00% | Reduce | |
| 528.99K | $629.50K | 0.12% | Hold | |
| 525.02K | $624.78K | 0.42% | Add | |
| 513.70K | $611.30K | 0.00% | Add | |
| 400.30K | $476.36K | 0.01% | Add | |
| 379.51K | $451.61K | 0.00% | Add | |
| 288.67K | $343.67K | 0.00% | New | |
| 288.67K | $343.67K | 0.00% | Reduce | |
| 264.39K | $314.62K | 0.85% | Hold | |
| 257.63K | $306.58K | 0.00% | Add | |
| 171.25K | $203.79K | 0.00% | Add | |
| 160.00K | $190.40K | 0.00% | Reduce | |
| 114.03K | $135.69K | 0.00% | Reduce | |
| 114.03K | $135.69K | 0.00% | Reduce | |
| 109.13K | $129.87K | 0.00% | Add | |
| 89.94K | $107.03K | 0.03% | Hold | |
| 72.12K | $85.82K | 0.01% | New | |
| 68.94K | $82.04K | 0.00% | Reduce | |
| 64.02K | $76.19K | 0.00% | Hold | |
| 55.71K | $66.29K | 0.00% | Add | |
| 53.40K | $63.55K | 0.00% | Hold | |
| 38.40K | $45.69K | 0.00% | Reduce | |
| 37.19K | $44.26K | 0.02% | Hold | |
| 17.85K | $21.24K | 0.00% | Add |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.06M | $1.42M | 0.00% | New | |
| 787.90K | $1.06M | 0.00% | Add | |
| 528.99K | $708.85K | 0.15% | Hold | |
| 516.76K | $682.91K | 0.56% | Add | |
| 496.77K | $665.67K | 0.00% | Add | |
| 395.80K | $530.37K | 0.01% | Hold | |
| 382.15K | $512.09K | 0.00% | New | |
| 358.20K | $480.16K | 0.00% | Add | |
| 264.39K | $354.28K | 2.38% | Hold | |
| 230.13K | $308.38K | 0.00% | Add | |
| 202.14K | $270.87K | 0.00% | Add | |
| 170.17K | $228.03K | 0.00% | New | |
| 170.10K | $227.94K | 0.00% | Reduce | |
| 170.10K | $227.94K | 0.00% | Reduce | |
| 151.44K | $202.93K | 0.00% | Reduce | |
| 120.43K | $161.37K | 0.00% | Hold | |
| 89.94K | $120.53K | 0.05% | Hold | |
| 78.64K | $105.37K | 0.00% | Add | |
| 75.17K | $100.73K | 0.00% | Hold | |
| 64.02K | $85.79K | 0.01% | Hold | |
| 53.40K | $71.56K | 0.00% | Hold | |
| 40.58K | $54.38K | 0.00% | Reduce | |
| 37.19K | $49.84K | 0.02% | Reduce | |
| 27.57K | $36.94K | 0.00% | Reduce | |
| 27.52K | $36.88K | 0.00% | Reduce |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.27M | $2.06M | 0.00% | Add | |
| 628.40K | $1.02M | 0.00% | Add | |
| 528.99K | $856.97K | 0.15% | Hold | |
| 497.65K | $806.20K | 0.69% | Reduce | |
| 441.39K | $715.05K | 0.00% | Add | |
| 433.86K | $702.85K | 0.00% | Add | |
| 395.80K | $641.20K | 0.01% | Add | |
| 305.91K | $495.76K | 0.00% | Add | |
| 264.39K | $428.31K | 1.60% | Hold | |
| 235.19K | $381.00K | 0.00% | Reduce | |
| 235.19K | $381.00K | 0.00% | Reduce | |
| 224.14K | $363.11K | 0.00% | Hold | |
| 201.30K | $326.11K | 0.00% | Add | |
| 178.17K | $288.64K | 0.00% | New | |
| 120.43K | $195.09K | 0.00% | Reduce | |
| 118.41K | $191.82K | 0.00% | Add | |
| 89.94K | $145.71K | 0.05% | Hold | |
| 79.14K | $128.20K | 0.00% | Reduce | |
| 75.17K | $121.78K | 0.00% | Add | |
| 68.99K | $111.77K | 0.00% | Add | |
| 64.02K | $103.71K | 0.01% | Reduce | |
| 59.68K | $96.69K | 0.00% | Reduce | |
| 56.50K | $91.53K | 0.00% | Add | |
| 53.40K | $86.51K | 0.01% | Hold | |
| 38.74K | $62.76K | 0.03% | Hold |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.24M | $2.94M | 0.00% | Reduce | |
| 528.99K | $1.25M | 0.23% | Hold | |
| 513.82K | $1.22M | 1.09% | Add | |
| 310.69K | $736.34K | 0.00% | Reduce | |
| 310.69K | $736.34K | 0.00% | Reduce | |
| 291.89K | $692.08K | 0.00% | Reduce | |
| 264.39K | $626.61K | 3.82% | Reduce | |
| 252.31K | $597.98K | 0.00% | Hold | |
| 241.33K | $571.96K | 0.00% | Reduce | |
| 223.45K | $529.58K | 0.00% | Reduce | |
| 207.53K | $491.84K | 0.00% | Add | |
| 195.80K | $464.05K | 0.01% | Add | |
| 167.00K | $395.79K | 0.00% | Add | |
| 121.54K | $288.04K | 0.00% | Reduce | |
| 102.01K | $241.76K | 0.00% | Add | |
| 98.25K | $232.86K | 0.00% | Reduce | |
| 91.31K | $216.39K | 0.00% | Reduce | |
| 89.94K | $213.17K | 0.06% | Hold | |
| 71.27K | $168.90K | 0.00% | New | |
| 70.78K | $167.75K | 0.01% | Reduce | |
| 62.56K | $148.26K | 0.00% | Add | |
| 53.40K | $126.56K | 0.01% | Hold | |
| 52.89K | $125.34K | 0.00% | New | |
| 50.40K | $119.45K | 0.00% | New | |
| 39.97K | $94.74K | 0.00% | Reduce |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.26M | $1.86M | 0.00% | Reduce | |
| 528.99K | $782.91K | 0.16% | Hold | |
| 508.11K | $751.99K | 0.75% | Add | |
| 383.03K | $566.89K | 0.00% | Add | |
| 383.03K | $566.89K | 0.00% | Add | |
| 296.36K | $438.62K | 0.00% | Reduce | |
| 293.46K | $434.32K | 0.00% | Reduce | |
| 952.13K | $391.30K | 2.35% | Add | |
| 252.31K | $373.42K | 0.00% | Hold | |
| 250.19K | $370.28K | 0.00% | Add | |
| 200.00K | $296.00K | 0.01% | Add | |
| 158.93K | $235.22K | 0.00% | New | |
| 150.29K | $222.43K | 0.00% | New | |
| 130.81K | $193.60K | 0.00% | Reduce | |
| 129.06K | $191.00K | 0.00% | Add | |
| 129.06K | $191.00K | 0.00% | Add | |
| 119.00K | $176.12K | 0.00% | Add | |
| 118.92K | $176.00K | 0.00% | Add | |
| 108.60K | $160.72K | 0.00% | Add | |
| 98.70K | $146.08K | 0.00% | Hold | |
| 98.40K | $145.63K | 0.00% | Reduce | |
| 89.94K | $133.12K | 0.03% | Hold | |
| 80.00K | $118.40K | 0.01% | New | |
| 72.59K | $107.43K | 0.00% | Add | |
| 61.83K | $91.51K | 0.00% | Reduce |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 288.67K sh · $343.67K
- Marquette Asset Management, LLC 72.12K sh · $85.82K
- Qube Research & Technologies Ltd 16.85K sh · $20.05K
- TWO SIGMA SECURITIES, LLC 15.17K sh · $18.06K
- BARCLAYS PLC 167 sh · $199
Fully Exited (vs previous quarter)
- STATE STREET CORP sold 120.43K sh · $161.37K
- Marshall Wace sold 27.52K sh · $36.88K
- LPL Financial LLC sold 16.83K sh · $22.56K
- Point72 Asset Management sold 11.73K sh · $15.71K
- HRT FINANCIAL LP sold 10.67K sh · $14.00K
- Russell Investments Group, Ltd. sold 4.18K sh · $5.60K
- NISA INVESTMENT ADVISORS, LLC sold 511 sh · $685
- Larson Financial Group LLC sold 50 sh · $67
- CWM, LLC sold 25 sh · $34
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 1.08M | 1.08M | 1.06M | — | — | — | — | — | — | — | — |
| Renaissance Technologies | 624.30K | 742.40K | 787.90K | 628.40K | 167.00K | 119.00K | 99.60K | 153.80K | 182.10K | — | — |
| Peapod Lane Capital LLC | 490.99K | 525.02K | 516.76K | 497.65K | 513.82K | 508.11K | 352.46K | 351.21K | — | — | — |
| Geode Capital Management | 275.09K | 288.67K | 358.20K | 305.91K | 291.89K | 293.46K | 619.57K | 587.42K | 338.03K | 164.24K | 86.76K |
| BlackRock Inc | 253.24K | 257.63K | 230.13K | 224.14K | 223.45K | 296.36K | 1.54M | 1.44M | 435.66K | — | — |
| VANGUARD FIDUCIARY TRUST CO | 171.25K | 171.25K | 170.17K | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 119.85K | — | 120.43K | 120.43K | 121.54K | 130.81K | 566.93K | 429.90K | 30.74K | 30.47K | — |
| RBF Capital, LLC | 64.02K | 64.02K | 64.02K | 64.02K | 70.78K | 80.00K | — | — | — | — | — |
| HRT FINANCIAL LP | 52.29K | — | 10.67K | 11.09K | 14.10K | 59.04K | — | — | — | — | 31.48K |
| Fortitude Advisory Group L.L.C. | 37.29K | 37.19K | 37.19K | 38.74K | 38.74K | 38.49K | 36.79K | 75.74K | — | — | — |
| Empowered Funds, LLC | 37.20K | — | — | — | — | — | — | — | — | — | — |
| JANE STREET GROUP, LLC | 22.82K | 38.40K | 151.44K | 433.86K | 98.25K | 158.93K | — | 29.76K | — | — | 12.33K |
| UBS Group AG | 15.91K | 15.79K | 16.10K | 25.10K | 23.49K | 118.92K | 67.75K | 39.05K | 9.06K | 2.16K | 1.68K |
| Vanguard Global Advisers, LLC | 13.39K | 13.39K | 13.39K | — | — | — | — | — | — | — | — |
| DIMENSIONAL FUND ADVISORS LP | 12.80K | 12.80K | 12.80K | 13.78K | — | — | — | — | — | — | — |
| Morgan Stanley | 6.37K | 5.30K | 27.57K | 59.68K | 241.33K | 250.19K | 193.75K | 775.79K | 64.64K | 44.72K | 9.21K |
| Nuveen, LLC | 4.05K | — | — | — | — | — | 63.25K | — | — | — | — |
| MEEDER ASSET MANAGEMENT INC | 5.50K | 5.50K | 5.50K | 5.50K | 5.50K | 5.50K | 5.12K | — | — | — | — |
| US BANCORP \DE\ | 4.50K | 4.50K | 4.50K | 4.50K | 4.50K | 4.50K | 4.50K | 4.50K | 4.50K | 4.50K | 4.50K |
| OSAIC HOLDINGS, INC. | 1.89K | 1.89K | 2.89K | 2.89K | 3.14K | 3.19K | 3.14K | 1.47K | 1.47K | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold MGX?
As of 2026-Q2, 44 institutional funds reported holding MGX (METAGENOMI THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $7.79M.
How many shares of MGX do institutions own?
13F filers reported 6.55M shares of MGX, worth $7.79M in aggregate at the end of 2026-Q2.
Is institutional ownership of MGX rising or falling?
Share counts moved -4.5% versus the prior quarter — distribution.
Who are the top institutional holders of MGX?
The largest 13F holders are Novo Holdings A/S, Principal Global Investors, RA CAPITAL MANAGEMENT, L.P., EVENTIDE ASSET MANAGEMENT, LLC, FARALLON CAPITAL MANAGEMENT, L.L.C.; the top 25 are ranked at the top of this page.
Who are the major shareholders of METAGENOMI THERAPEUTICS INC?
The major shareholders of METAGENOMI THERAPEUTICS INC (MGX) by reported 13F value are Novo Holdings A/S, Principal Global Investors, RA CAPITAL MANAGEMENT, L.P., EVENTIDE ASSET MANAGEMENT, LLC, FARALLON CAPITAL MANAGEMENT, L.L.C., among 141 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.